Thanks for signing up for DividendStocks.com! It's the daily newsletter built for dividend and income investors. Before we can begin sending your daily updates, there’s one quick step left. Please confirm your subscription using the link below so our emails reach your inbox. Click Here to Confirm Your Subscription to DividendStocks.com Here’s a small glimpse of what you’ll get access to: Dividend Stock Ideas — Each newsletter features dividend stocks with high yields, sustainable payouts, and strong growth potential. Ex-Dividend Stocks — Want to capture upcoming dividend payouts? Find out which stocks are going ex-dividend this week. Market News and Events — Stay in the loop on the latest developments impacting popular dividend names like AT&T, Exxon Mobil, IBM, Procter & Gamble, and Verizon. Bonus: As a thank-you for confirming, you’ll also receive a free PDF copy of Automatic Income, our popular guide to building wealth through dividend investing. Let’s get your dividend journey started! Discover Top Income-Generating Stocks Here See you in your inbox soon,
The DividendStocks.com Team P.S. Don’t miss out click here to verify your subscription and secure your daily dividend insights and your free investing guide!
Additional Reading from MarketBeat Media The 3 Penny Stocks You Swore You'd Never Buy (But You'll Check Anyway)Written by Chris Markoch. Posted: 1/18/2026. 
Key Points - Vaxart is a clinical-stage biotech developing oral vaccines that could transform global immunization if its platform proves effective.
- Microvision develops cost-effective lidar technology for autonomous vehicles, with upside tied to industry adoption and potential partnerships.
- Datavault AI focuses on monetizing digital data through AI and blockchain tools, offering speculative exposure to the emerging data-as-an-asset theme.
Penny stocks attract speculative investors seeking high-risk, high-reward opportunities. Investors typically look for companies with disruptive technologies, those riding an emerging trend, or firms with compelling turnaround stories. Many of these businesses will never scale, but if even one succeeds, gains can be substantial. For investors who believe strength lies in numbers, MarketBeat offers a tool that lists the 100 Most Popular Penny Stocks, ranked by the number of MarketBeat subscribers following each company. While that's no guarantee of success, it can give an investor additional conviction in a stock's potential. Just like Microsoft and Adobe rode the software wave in Web 1.0, RAD Intel is riding the AI software wave in 2025. Their product helps brands instantly find the right audience and message using AI – solving the #1 waste in marketing: misfired ad spend.
Already trusted by a who's-who of Fortune 1000 brands and leading global agencies – with recurring seven-figure partnerships in place. With a Nasdaq ticker reserved, $RADI, it's early – but very real. $0.85 Won't Last – Secure Your Shares Now. Some investors define a penny stock as any share trading at $5 or less, but the screener used here follows the traditional definition: stocks priced below $1. These names are highly volatile. Do your own research and understand your risk tolerance before initiating a position. Vaxart: A Potential Game-Changer for Global Immunization Efforts Vaxart Inc. (NASDAQ: VXRT) is a clinical-stage biotechnology company developing oral vaccines for infectious diseases such as influenza, norovirus and COVID-19. Unlike traditional injectable vaccines, Vaxart's tablet-based platform aims to simplify distribution and improve global accessibility. The bull case for Vaxart centers on its novel delivery approach. If the company secures regulatory approval and scales manufacturing, its oral vaccines could reduce logistical barriers to mass immunization and create meaningful licensing opportunities. Positive trial results or a commercial partnership could materially shift sentiment and valuation from current levels. Clinical risk, however, is the primary challenge. Vaxart has not yet brought a product to market, and vaccine development is costly and unpredictable. Competition from established players with larger R&D budgets also constrains visibility. For now, Vaxart is a long-term speculative bet on platform validation rather than near-term profitability. The MarketBeat analyst coverage for Vaxart is minimal—only a single analyst tracks the stock—which should temper investor expectations. The company reports just 18% institutional ownership. On the plus side, short interest is roughly 2%, which may help limit some downside volatility. Microvision: Developing Cost-Effective LiDAR Units for Autonomous Driving Microvision Inc. (NASDAQ: MVIS) develops LiDAR (light detection and ranging) sensors for autonomous vehicles, smart infrastructure and industrial sensing. Its hardware and software enable precise 3D mapping required for self-driving systems and advanced driver-assistance systems (ADAS). Microvision focuses on compact, cost-effective LiDAR units that could appeal to automakers seeking scalable sensor solutions. The bull case for Microvision rests on broader adoption of vehicle automation and potential partnerships with major automakers. If the company can demonstrate performance or cost advantages, it could land supply agreements or licensing deals that boost revenue visibility. Microvision's technology may also find applications in robotics and smart-city projects, adding growth optionality. However, Microvision faces stiff competition from LiDAR firms such as Luminar (NASDAQ: LAZR), Innoviz (NASDAQ: INVZ) and Ouster (NYSE: OUST). The path to profitability is uncertain, and recurring delays in LiDAR adoption have frustrated investors. MVIS is covered by three analysts and carries a consensus price target of $2.50, implying a potential 169% increase from its Jan. 15 close. Like many speculative names, Microvision has relatively low institutional ownership (around 30%) and elevated short interest (about 21%), factors that can drive significant volatility. Datavault AI: Trying to Democratize Data Ownership Datavault AI Inc. (NASDAQ: DVLT) operates at the intersection of artificial intelligence, data monetization and digital asset management. The company helps organizations convert raw data into tradable, revenue-generating assets through its patented Datavault platform. By combining AI, blockchain and analytics, Datavault AI aims to democratize data ownership and unlock monetization opportunities that traditional systems often overlook. The bullish thesis for Datavault AI is its niche focus and scalability potential. As data grows in value, businesses—and potentially individuals—are looking for ways to safely monetize digital information. Datavault's platform could benefit from expanding AI adoption and increasing emphasis on data sovereignty. Early traction or strategic partnerships could act as catalysts for the stock. Still, Datavault AI operates in a highly experimental space. Its business model is evolving, and the path to meaningful revenue is unproven. Institutions own under 1% of the shares, and short interest exceeds 16% as of this writing. Investors considering DVLT should view it as a long-term, speculative position based on belief in data-as-an-asset innovation rather than near-term earnings potential.
| 
